Genmab A/S
SWB:GE9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genmab A/S
SWB:GE9
|
DK |
|
Hochschild Mining PLC
OTC:HCHDY
|
UK |
|
S
|
St Joe Co
XMUN:JOE
|
US |
|
Barsele Minerals Corp
XTSX:FNM
|
CA |
|
Aqylon Nexus Ltd
NSE:AQYLON
|
IN |
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
DK |
|
M
|
Manz AG
DUS:M5Z
|
DE |
|
Link Mobility Group Holding ASA
OTC:LMGHF
|
NO |
|
R
|
Ryman Healthcare Ltd
F:RH7
|
NZ |
|
D
|
Daily Mail and General Trust P L C
F:DGW2
|
UK |
|
N
|
Nesco Ltd
NSE:NESCO
|
IN |
|
PubMatic Inc
NASDAQ:PUBM
|
US |
|
Instalco AB
F:4IIA
|
SE |
|
Banque Cantonale Vaudoise
F:B1V1
|
CH |
|
A
|
Ackermans & Van Haaren NV
DUS:B3K
|
BE |
|
G
|
Globe Life Inc
XBER:TMJ
|
US |
|
V
|
Vanquis Banking Group PLC
SWB:PRVA
|
UK |
|
Getty Realty Corp
NYSE:GTY
|
US |
|
V
|
Varengold Bank AG
XMUN:VG8
|
DE |
|
E
|
Erste Group Bank AG
DUS:EBO
|
AT |
|
C
|
Chemring Group PLC
F:CMN1
|
UK |
|
Loandepot Inc
F:LDD
|
US |
|
City Developments Ltd
F:CDE0
|
SG |
|
N
|
Novatek PAO
LSE:NVTK
|
RU |
Bankruptcy Probability
Genmab A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Genmab A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Genmab A/S
CSE:GMAB
|
99.2B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Genmab A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Genmab A/S has total debt of 5.1B DKK. This includes both short-term (0 DKK) and long-term (5.1B DKK) debt.
You can find a full breakdown on its Balance Sheet.
